Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Inovio Pharmaceuticals
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of California, San Francisco
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Washington University School of Medicine
Sun Yat-sen University
Novartis
Janssen Pharmaceutica N.V., Belgium
M.D. Anderson Cancer Center
Abramson Cancer Center at Penn Medicine
St. Joseph's Hospital and Medical Center, Phoenix
University Health Network, Toronto
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Weill Medical College of Cornell University
UNICANCER
Alliance for Clinical Trials in Oncology
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
Mayo Clinic
Abramson Cancer Center at Penn Medicine
Merck Sharp & Dohme LLC
Ohio State University Comprehensive Cancer Center
Children's Oncology Group
NRG Oncology
Emory University
Mayo Clinic
NRG Oncology
University of California, Davis
H. Lee Moffitt Cancer Center and Research Institute
University of Iowa
The Netherlands Cancer Institute